Showing Results for
- Academic Journals (68)
Search Results
- 68
Academic Journals
- 68
- Search Terms:
- 1From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedPublished data on the association between XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer risk are inconclusive. In order to derive a more precise estimation of the relationship, a meta-analysis was performed....
- 2From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedThe mutation spectrum of BRCA1 and BRCA2 presents a wide range of unique mutations in breast/ovarian cancer patients but recurrent mutations with founder effects have also been described. BRCA2 5344delAATA and 9538delAA...
- 3From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedThere is growing evidence that uncontrolled activation of the PI3K/Akt/mTOR pathway contributes to the development and progression of breast cancer. Inhibition of this pathway has antitumour effects in preclinical...
- 4From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedEstrogen receptor [alpha] (ER[alpha]) is highly regulated through multiple mechanisms including cell signaling, posttranslational modifications, and protein-protein interactions. We have previously identified a K303R...
- 5From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedRegression of established tumors can be induced by adoptive immunotherapy (AIT) with tumor draining lymph node (DLN) lymphocytes activated with bryostatin and ionomycin (B/I). Tumor antigen-sensitized DLN lymphocytes...
- 6From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedTo the Editor Identification of founder mutations in various ethnic groups is important to improve genetic screening and cancer risk assessment because it makes a more specific approach for molecular testing that...
- 7From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedEstrogen receptor [alpha] (ER[alpha]) is highly regulated through multiple mechanisms including cell signaling, posttranslational modifications, and protein-protein interactions. We have previously identified a K303R...
- 8From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedIn order to shed light on genetic and environmental factors contributing to breast cancer health disparities, anonymous data from the cancer registry in Brooklyn, NY and two countries in the Caribbean, have been...
- 9From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedWe demonstrate here that functional NMDAR1 and NMDAR2 receptors are expressed by Mcf-7 and SKBR3 breast cancer cell lines, and possibly by most or all high-grade breast tumors, and that these receptors are important for...
- 10From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedBreast cancer is the most prevalent cancer in the world, which is a major public health challenge. To date, many publications have evaluated the correlation between Cytochrome P450 1A1 (CYP1A1) T3801C polymorphism and...
- 11From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedFeasibility and oncological safety of post-adjuvant skin-sparing mastectomy (SSM) plus immediate breast reconstruction (IBR) cannot be evaluated by randomized trials. However, comparative study could modify guidelines...
- 12From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedThe functional Ser326Cys polymorphism in the human 8-oxogunaine DNA glycosylase (hOGG1) gene has been implicated in breast cancer risk. However, the published findings are inconsistent. We therefore performed a...
- 13From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedDoxorubicin (DOX), despite causing cardiac toxicity, is an anthracycline chemotherapeutic agent that plays an important role in the treatment of breast cancer. Angiotensin-converting enzyme inhibitors (ACE-I) may...
- 14From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedBreast cancer is the most common cancer in women worldwide, but its etiology is still unclear. It is believed that oxidative stress plays an essential role in the development of breast cancer, while SOD2 is one of the...
- 15From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedThe mutation spectrum of BRCA1 and BRCA2 presents a wide range of unique mutations in breast/ovarian cancer patients but recurrent mutations with founder effects have also been described. BRCA2 5344delAATA and 9538delAA...
- 16From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedThe association of CYP19 gene polymorphisms with breast cancer has been widely reported, but results of previous studies were somewhat contradictory and underpowered. In order to overcome the limitations of individual...
- 17From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedWomen with recurrent metastatic breast cancer from a Spanish hospital registry (El Alamo, GEICAM) were analyzed in order to identify the most helpful prognostic factors to predict survival and to ultimately construct a...
- 18From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedStudies of gene regulated by estrogen in breast cancer 1 (GREB1) have focused on mRNA levels with limited evidence about GREB1 protein expression in normal and breast cancer cells. A monoclonal antibody that recognizes...
- 19From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedWomen with recurrent metastatic breast cancer from a Spanish hospital registry (El Alamo, GEICAM) were analyzed in order to identify the most helpful prognostic factors to predict survival and to ultimately construct a...
- 20From: Breast Cancer Research and Treatment. (Vol. 122, Issue 2) Peer-ReviewedSince an overarching goal of Healthy People 2010 was to eliminate health disparities, we determined temporal trends in socioeconomic disparities in five breast-cancer indicators (in situ, stage I, lymph-node positive,...